InspireMD Inc (NSPR) Sees Large Drop in Short Interest

InspireMD Inc (NYSEAMERICAN:NSPR) was the recipient of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 1,380,239 shares, a decrease of 26.2% from the December 14th total of 1,869,651 shares. Based on an average trading volume of 732,618 shares, the days-to-cover ratio is presently 1.9 days. Approximately 3.9% of the company’s stock are short sold.

NSPR opened at $0.19 on Friday. InspireMD has a 52-week low of $0.13 and a 52-week high of $9.17.

InspireMD (NYSEAMERICAN:NSPR) last posted its quarterly earnings data on Tuesday, November 6th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The firm had revenue of $0.77 million for the quarter.

COPYRIGHT VIOLATION WARNING: This piece of content was first posted by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.themarketsdaily.com/2019/01/13/inspiremd-inc-nspr-sees-large-drop-in-short-interest.html.

InspireMD Company Profile

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.

See Also: What are the economic characteristics of a bear market?

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply